Coronavirus vaccine - GlaxoSmithKline/Institut Pasteur

Drug Profile

Coronavirus vaccine - GlaxoSmithKline/Institut Pasteur

Alternative Names: SARS vaccine - GlaxoSmithKline/Institut Pasteur

Latest Information Update: 27 Aug 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator GlaxoSmithKline; Institut Pasteur
  • Class Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Coronavirus infections

Most Recent Events

  • 27 Aug 2007 No development reported - Preclinical for Coronavirus infections in Belgium (unspecified route)
  • 27 Aug 2007 No development reported - Preclinical for Coronavirus infections in France (unspecified route)
  • 28 Apr 2004 Preclinical trials in Coronavirus infections in Belgium (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top